Ymabs
1 known investors
Y-mAbs develops radioimmunotherapy and antibody-based therapies targeting pediatric and adult cancers, with a heritage in high-risk neuroblastoma and expansion into additional oncology indications.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
TG
Thomas GadFounder, Vice Chairman of the Board of Directors, and Chief Business Officer